CellOrigin Biotech
Hangzhou
About CellOrigin Biotech
CellOrigin Biotech is a company committed to iPSC-derived innate immune cell therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $15.7M
- Last round: Series Unknown (Sep 2023)
- Website: en.cell-origin.com
- Phone: 178-0581-5679
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/cellorigin-biotech-43762 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.